Prevalence of HIV , HBV , and HCV in United States blood donations, 2015–2023: The transfusion‐transmissible infections monitoring system ( TTIMS )
Transfusion · 2025
DOI: 10.1111/trf.18424 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transfusion, 2025. Verfasst von Emilya Huseynova und 9 weiteren Autor:innen. Beteiligte Einrichtung: Transfusion Safety and Surveillance, American Red Cross, Rockville, Maryland, USA. Hauptthemen laut MEDLINE: Blood Donors, HIV Infections, Hepatitis C, Hepatitis B. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: U.S. Food and Drug Administration.
Abstract (Originalsprache)
Background
The Transfusion‐Transmissible Infections Monitoring System assesses trends in ~60% of the US blood supply. Donors with high‐risk behaviors, including injection drug users, men having sex with other men, or those exchanging sex for money/drugs, were deferred for 12 months (12 M) from 2016 to 2020 and 3 months (3M) from 2020 to 2023. Here we evaluate HIV, HBV, and HCV donation prevalence annually from 2015 to 2023 and in two comparison periods of pre‐3M (2015–2020) and 3M (2020–2023) to identify differences between the two periods.
Methods
Annual prevalence was assessed for 8 TTIMS years (2015–2023) and compared between the pre‐3M and 3M periods. HIV, HBV, and HCV prevalence/100,000 donations (phtd) was calculated based on serology and nucleic acid testing results. Negative binomial regression assessed prevalence using 1‐year intervals. Fisher's exact test evaluated prevalence changes between the two periods ( α = 0.05).
Results
Annual HIV and HBV prevalence remained stable, changing slightly from year 1 to 8 (2.5–2.1 phtd for HIV and 6.3–6.6 phtd for HBV). HCV prevalence declined (19.7–9.6 phtd; p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Transfusion Safety and Surveillance, American Red Cross, Rockville, Maryland, USA.
- Department of Epidemiology, Vitalant Research Institute, San Francisco, California, USA.
- Scientific, Medical, and Technical Division, OneBlood, St. Petersburg, Florida, USA.
- Physician Services, New York Blood Center Enterprises, New York, New York, USA.
- Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
- National Institutes of Health, Infectious Disease Consultant, North Potomac, Maryland, USA.
ORCID-Profile: Emilya Huseynova, Brian Custer, Jed Gorlin, Roger Y Dodd, Susan L Stramer
Förderung
- U.S. Food and Drug Administration
Zitieren
APA
Huseynova, E., Haynes, J., Notari, E. P., Custer, B., Reik, R., Gorlin, J., Belov, A., Yang, H., Dodd, R. Y., & Stramer, S. L. (2025). Prevalence of HIV , HBV , and HCV in United States blood donations, 2015–2023: The transfusion‐transmissible infections monitoring system ( TTIMS ). Transfusion. https://doi.org/10.1111/trf.18424
Vancouver
Huseynova E, Haynes J, Notari EP, Custer B, Reik R, Gorlin J, et al. Prevalence of HIV , HBV , and HCV in United States blood donations, 2015–2023: The transfusion‐transmissible infections monitoring system ( TTIMS ). Transfusion. 2025. doi:10.1111/trf.18424
BibTeX
@article{Huseynova2025,
author = {Huseynova, Emilya and Haynes, James and Notari, Edward P and Custer, Brian and Reik, Rita and Gorlin, Jed and Belov, Artur and Yang, Hong and Dodd, Roger Y and Stramer, Susan L},
title = {Prevalence of HIV , HBV , and HCV in United States blood donations, 2015–2023: The transfusion‐transmissible infections monitoring system ( TTIMS )},
journal = {Transfusion},
year = {2025},
doi = {10.1111/trf.18424}
}
EUVIMED